Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Preclinical Activity of a New Proteasome Inhibitor, MLN9708, in Acute Myelogenous Leukemias Expressing NPM1 Mutated Protein

Jacqueline S Garcia, MD, Min Huang, Bruno C Medeiros, MD, Beverly S. Mitchell, MD

Blood (2014) 124 (21): 993.

https://doi.org/10.1182/blood.V124.21.993.993

Published: 2014

Journal Articles

Defective Hematopoiesis and Erythroid Differentiation Resulting From Telomerase Deficiency

Aparna Raval, PhD, Brenda Kusler, BS, Steven Artandi, MD, PhD, Beverly S. Mitchell, MD

Blood (2011) 118 (21): 2410.

https://doi.org/10.1182/blood.V118.21.2410.2410

Published: 2011

Journal Articles

A Novel Missense Mutation In An MDS Patient and Effects on TET2 mRNA Expression and Clinical Outcomes

Daniel A Pollyea, MD, Aparna Raval, PhD, Brenda Kusler, Jason R Gotlib, MD, MS, Ash A. Alizadeh, MD, PhD, Beverly S. Mitchell, MD

Blood (2010) 116 (21): 1889.

https://doi.org/10.1182/blood.V116.21.1889.1889

Published: 2010

Journal Articles

Ribosomal RNA Expression In CD34+ Hematopoietic Progenitor Cells Inversely Correlates with Ribosomal DNA Methylation In Myelodysplastic Syndromes.

Aparna Raval, PhD, Daniel A Pollyea, MD, Kunju J Shridhar, PhD, Shripa Patel, Peter L. Greenberg, MD, Beverly S. Mitchell, MD

Blood (2010) 116 (21): 1682.

https://doi.org/10.1182/blood.V116.21.1682.1682

Published: 2010

Journal Articles

A Phase I Study of Sequential Azacitidine and Lenalidomide for Elderly Patients with Acute Myeloid Leukemia (AML)

Daniel A Pollyea, MD, Holbrook E Kohrt, MD, Leonel Gallegos, MD, Caroline Berube, MD, Steven Coutre, MD, Jason Gotlib, M.D., M.S., Michaela Liedtke, MD, Beverly S. Mitchell, MD, Bruno C. Medeiros, MD

Blood (2010) 116 (21): 3288.

https://doi.org/10.1182/blood.V116.21.3288.3288

Published: 2010

Journal Articles

Clinical-Biomarker Correlations in Adult AML Patients in a Phase I Trial of AVN944 Support Observations of Clinical Effect and Provide Hypotheses for Patient Selection Criteria for Further Clinical Trials.

Rebecca B. Klisovic, MD, Steven Coutre, MD, Tibor J. Kovacsovics, MD, Hagop M. Kantarjiam, MD, Guido J. Tricot, MD, Jeffrey W. Strovel, PhD, Thomas Genna, RhP, David K. Bol, PhD, Michael Hamilton, MD, Beverly S. Mitchell, MD

Blood (2007) 110 (11): 896.

https://doi.org/10.1182/blood.V110.11.896.896

Published: 2007

Journal Articles

A Systematic Review Evaluating the Addition of Radiation Therapy to Chemotherapy for Localized Aggressive Non-Hodgkin’s Lymphoma: What Is the Role for Radiotherapy?.

Daniel B. Fried, MD, PhD, David E. Morris, MD, Thomas C. Shea, MD, Robert Z. Orlowski, MD, PhD, Hendrik W. Van Deventer, MD, Beverly S. Mitchell, MD

Blood (2004) 104 (11): 3155.

https://doi.org/10.1182/blood.V104.11.3155.3155

Published: 2004

NARROW

Preclinical Activity of a New Proteasome Inhibitor, MLN9708, in Acute Myelogenous Leukemias Expressing NPM1 Mutated Protein

Defective Hematopoiesis and Erythroid Differentiation Resulting From Telomerase Deficiency

A Novel Missense Mutation In An MDS Patient and Effects on TET2 mRNA Expression and Clinical Outcomes

Ribosomal RNA Expression In CD34+ Hematopoietic Progenitor Cells Inversely Correlates with Ribosomal DNA Methylation In Myelodysplastic Syndromes.

A Phase I Study of Sequential Azacitidine and Lenalidomide for Elderly Patients with Acute Myeloid Leukemia (AML)

Clinical-Biomarker Correlations in Adult AML Patients in a Phase I Trial of AVN944 Support Observations of Clinical Effect and Provide Hypotheses for Patient Selection Criteria for Further Clinical Trials.

A Systematic Review Evaluating the Addition of Radiation Therapy to Chemotherapy for Localized Aggressive Non-Hodgkin’s Lymphoma: What Is the Role for Radiotherapy?.

Email alerts

ASH Publications

American Society of Hematology

Preclinical Activity of a New Proteasome Inhibitor, MLN9708, in Acute Myelogenous Leukemias Expressing NPM1 Mutated Protein

Defective Hematopoiesis and Erythroid Differentiation Resulting From Telomerase Deficiency

A Novel Missense Mutation In An MDS Patient and Effects on TET2 mRNA Expression and Clinical Outcomes

Ribosomal RNA Expression In CD34+ Hematopoietic Progenitor Cells Inversely Correlates with Ribosomal DNA Methylation In Myelodysplastic Syndromes.

A Phase I Study of Sequential Azacitidine and Lenalidomide for Elderly Patients with Acute Myeloid Leukemia (AML)

Clinical-Biomarker Correlations in Adult AML Patients in a Phase I Trial of AVN944 Support Observations of Clinical Effect and Provide Hypotheses for Patient Selection Criteria for Further Clinical Trials.

A Systematic Review Evaluating the Addition of Radiation Therapy to Chemotherapy for Localized Aggressive Non-Hodgkin’s Lymphoma: What Is the Role for Radiotherapy?.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only